Earnings Preview: COLL to Report Financial Results Post-market on November 07
$Collegium Pharmaceutical(COLL.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Collegium Pharmaceutical(COLL.US)$ to post revenue
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $37